<bill session="115" type="h" number="5684" updated="2019-04-18T16:23:04Z">
  <state datetime="2018-05-09">REPORTED</state>
  <status>
    <unknown datetime="2018-05-09"/>
  </status>
  <introduced datetime="2018-05-07"/>
  <titles>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to expand eligibility for medication therapy management programs established under part D of the Medicare program to include certain individuals who are at risk for prescription drug abuse.</title>
    <title type="short" as="reported to house">Protecting Seniors From Opioid Abuse Act</title>
    <title type="short" as="reported to house">Protecting Seniors From Opioid Abuse Act</title>
    <title type="short" as="introduced">Protecting Seniors From Opioid Abuse Act</title>
    <title type="short" as="introduced">Protecting Seniors From Opioid Abuse Act</title>
    <title type="display">Protecting Seniors From Opioid Abuse Act</title>
  </titles>
  <sponsor bioguide_id="K000376"/>
  <cosponsors>
    <cosponsor bioguide_id="B001243" joined="2018-05-10"/>
    <cosponsor bioguide_id="D000619" joined="2018-06-08"/>
    <cosponsor bioguide_id="D000482" joined="2018-05-07"/>
    <cosponsor bioguide_id="H001056" joined="2018-05-25"/>
    <cosponsor bioguide_id="M001159" joined="2018-05-07"/>
    <cosponsor bioguide_id="P000599" joined="2018-06-05"/>
    <cosponsor bioguide_id="T000460" joined="2018-05-07"/>
    <cosponsor bioguide_id="W000791" joined="2018-05-23"/>
  </cosponsors>
  <actions>
    <action datetime="2018-05-07">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-05-07" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-05-07">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-05-08">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2018-05-09">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <calendar datetime="2018-05-09" state="REPORTED">
      <text>Ordered to be Reported by Voice Vote.</text>
    </calendar>
    <action datetime="2018-06-12">
      <text>Reported by the Committee on Energy and Commerce. H. Rept. 115-742, Part I.</text>
    </action>
    <action datetime="2018-06-12">
      <text>Committee on Ways and Means discharged.</text>
    </action>
    <calendar datetime="2018-06-12" calendar="Union" number="576">
      <text>Placed on the Union Calendar, Calendar No. 576.</text>
    </calendar>
  </actions>
  <committees>
    <committee subcommittee="" code="HSWM" name="House Ways and Means" activity="Discharged, Referral"/>
    <committee subcommittee="Health" code="HSWM02" name="House Ways and Means" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="unknown" number="5773"/>
    <bill type="h" session="115" relation="unknown" number="6"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Drug therapy"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2018-06-12T14:59:22Z" status="Reported to House without amendment, Part I">Protecting Seniors From Opioid Abuse Act

This bill establishes individuals who are identified as at-risk beneficiaries for prescription drug abuse as qualifying participants in medication therapy management programs under the Medicare prescription drug benefit.</summary>
  <committee-reports>
    <report>H. Rept. 115-742</report>
  </committee-reports>
</bill>
